Doç.Dr. BURAK TANYILDIZ

Real-World Efficacy and Safety of Escalation to Weekly Adalimumab for Chronic Non-Infectious Uveitis: A Multicenter Study Involving Pediatric and Adult Patients

(2025). Ocular Immunology and Inflammation, 1-10. Oklar, M., İnanç Tekin, M., Özdemir Yalçınsoy, K., Zorlutuna Kaymak, N., Tanyildiz, B., & Özdal, P. Ç.

Treatment Adherence Effect on the Visual Acuity of Behçet?s Uveitis Patients

Ocular Immunology and Inflammation, 2024;32(8); 1698-1706. Oklar, M., Zorlutuna Kaymak, N., Tanyildiz, B., Tezcan, M. E., & Şimşek, Ş.

Evaluating the quality, utility, and reliability of the information in uveitis videos shared on YouTube

International Ophthalmology, 2023 43(2), 549-555. Tanyıldız, B., & Oklar, M.